Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 55 entries
Sorted by: Best Match Show Resources per page
Long-term follow-up of post-stroke epilepsy after ischemic stroke: Room for improved epilepsy treatment.

Seizure

Redfors P, Holmegaard L, Pedersen A, Jern C, Malmgren K.
PMID: 32014726
Seizure. 2020 Jan 21;76:50-55. doi: 10.1016/j.seizure.2020.01.009. Epub 2020 Jan 21.

PURPOSE: To assess long-term incidence and predictors of post-stroke epilepsy (PSE) and to evaluate the antiepileptic drug (AED) treatment in a well characterized cohort of middle-aged patients.METHODS: The study is based on the Sahlgrenska Study on Ischemic stroke, and...

Cite
Redfors P, Holmegaard L, Pedersen A, et al. Long-term follow-up of post-stroke epilepsy after ischemic stroke: Room for improved epilepsy treatment. Seizure. 2020;76:50-55doi: 10.1016/j.seizure.2020.01.009.
Redfors, P., Holmegaard, L., Pedersen, A., Jern, C., & Malmgren, K. (2020). Long-term follow-up of post-stroke epilepsy after ischemic stroke: Room for improved epilepsy treatment. Seizure, 7650-55. https://doi.org/10.1016/j.seizure.2020.01.009
Redfors, Petra, et al. "Long-term follow-up of post-stroke epilepsy after ischemic stroke: Room for improved epilepsy treatment." Seizure vol. 76 (2020): 50-55. doi: https://doi.org/10.1016/j.seizure.2020.01.009
Redfors P, Holmegaard L, Pedersen A, Jern C, Malmgren K. Long-term follow-up of post-stroke epilepsy after ischemic stroke: Room for improved epilepsy treatment. Seizure. 2020 Jan 21;76:50-55. doi: 10.1016/j.seizure.2020.01.009. Epub 2020 Jan 21. PMID: 32014726.
Copy Download .nbib Format: NLM
Spectrum and energy levels of the xenonlike ion Ce V.

Physical review. A, Atomic, molecular, and optical physics

Reader J, Redfors A.
PMID: 9905285
Phys Rev A. 1991 Mar 01;43(5):2367-2373. doi: 10.1103/physreva.43.2367.

No abstract available.

Cite
Reader J, Redfors A. Spectrum and energy levels of the xenonlike ion Ce V. Phys Rev A. 1991;43(5):2367-2373doi: 10.1103/physreva.43.2367.
Reader, J., & Redfors, A. (1991). Spectrum and energy levels of the xenonlike ion Ce V. Physical review. A, Atomic, molecular, and optical physics, 43(5), 2367-2373. https://doi.org/10.1103/physreva.43.2367
Reader, and Redfors. "Spectrum and energy levels of the xenonlike ion Ce V." Physical review. A, Atomic, molecular, and optical physics vol. 43,5 (1991): 2367-2373. doi: https://doi.org/10.1103/physreva.43.2367
Reader J, Redfors A. Spectrum and energy levels of the xenonlike ion Ce V. Phys Rev A. 1991 Mar 01;43(5):2367-2373. doi: 10.1103/physreva.43.2367. PMID: 9905285.
Copy Download .nbib Format: NLM
Successful pregnancy and delivery in a woman with panhypopituitarism.

The Libyan journal of medicine

Ashawesh K, Abdulqawi R, Redford D, Barton D.
PMID: 21503236
Libyan J Med. 2007 Dec 01;2(4):163. doi: 10.4176/070719.

No abstract available.

Cite
Ashawesh K, Abdulqawi R, Redford D, et al. Successful pregnancy and delivery in a woman with panhypopituitarism. Libyan J Med. 2007;2(4):163doi: 10.4176/070719.
Ashawesh, K., Abdulqawi, R., Redford, D., & Barton, D. (2007). Successful pregnancy and delivery in a woman with panhypopituitarism. The Libyan journal of medicine, 2(4), 163. https://doi.org/10.4176/070719
Ashawesh, K, et al. "Successful pregnancy and delivery in a woman with panhypopituitarism." The Libyan journal of medicine vol. 2,4 (2007): 163. doi: https://doi.org/10.4176/070719
Ashawesh K, Abdulqawi R, Redford D, Barton D. Successful pregnancy and delivery in a woman with panhypopituitarism. Libyan J Med. 2007 Dec 01;2(4):163. doi: 10.4176/070719. PMID: 21503236; PMCID: PMC3078244.
Copy Download .nbib Format: NLM
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk.

Journal of the American College of Cardiology

Palmerini T, Bruno AG, Redfors B, Valgimigli M, Taglieri N, Feres F, Abizaid A, Costa R, Gilard M, Morice MC, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Nakamura M, Kotinkaduwa LN, Nardi E, Saia F, Gasparini M, Rizzello G, Weisz G, Kirtane AJ, Mehran R, Witzenbichler B, Galiè N, Stone GW.
PMID: 34763774
J Am Coll Cardiol. 2021 Nov 16;78(20):1968-1986. doi: 10.1016/j.jacc.2021.08.070.

BACKGROUND: Although a 1-year duration of dual antiplatelet therapy (DAPT) is used in many patients after drug-eluting stent (DES) implantation, the evidence supporting this duration is uncertain.OBJECTIVES: The authors investigated the risk-benefit profile of 1-year vs ≤6-month DAPT after...

Cite
Palmerini T, Bruno AG, Redfors B, et al. Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. J Am Coll Cardiol. 2021;78(20):1968-1986doi: 10.1016/j.jacc.2021.08.070.
Palmerini, T., Bruno, A. G., Redfors, B., Valgimigli, M., Taglieri, N., Feres, F., Abizaid, A., Costa, R., Gilard, M., Morice, M. C., Hong, M. K., Kim, B. K., Jang, Y., Kim, H. S., Park, K. W., Colombo, A., Chieffo, A., Nakamura, M., Kotinkaduwa, L. N., Nardi, E., Saia, F., Gasparini, M., Rizzello, G., Weisz, G., Kirtane, A. J., Mehran, R., Witzenbichler, B., Galiè, N., & Stone, G. W. (2021). Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. Journal of the American College of Cardiology, 78(20), 1968-1986. https://doi.org/10.1016/j.jacc.2021.08.070
Palmerini, Tullio, et al. "Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk." Journal of the American College of Cardiology vol. 78,20 (2021): 1968-1986. doi: https://doi.org/10.1016/j.jacc.2021.08.070
Palmerini T, Bruno AG, Redfors B, Valgimigli M, Taglieri N, Feres F, Abizaid A, Costa R, Gilard M, Morice MC, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Nakamura M, Kotinkaduwa LN, Nardi E, Saia F, Gasparini M, Rizzello G, Weisz G, Kirtane AJ, Mehran R, Witzenbichler B, Galiè N, Stone GW. Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. J Am Coll Cardiol. 2021 Nov 16;78(20):1968-1986. doi: 10.1016/j.jacc.2021.08.070. PMID: 34763774.
Copy Download .nbib Format: NLM
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk.

Journal of the American College of Cardiology

Palmerini T, Bruno AG, Redfors B, Valgimigli M, Taglieri N, Feres F, Abizaid A, Costa R, Gilard M, Morice MC, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Nakamura M, Kotinkaduwa LN, Nardi E, Saia F, Gasparini M, Rizzello G, Weisz G, Kirtane AJ, Mehran R, Witzenbichler B, Galiè N, Stone GW.
PMID: 34763774
J Am Coll Cardiol. 2021 Nov 16;78(20):1968-1986. doi: 10.1016/j.jacc.2021.08.070.

BACKGROUND: Although a 1-year duration of dual antiplatelet therapy (DAPT) is used in many patients after drug-eluting stent (DES) implantation, the evidence supporting this duration is uncertain.OBJECTIVES: The authors investigated the risk-benefit profile of 1-year vs ≤6-month DAPT after...

Cite
Palmerini T, Bruno AG, Redfors B, et al. Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. J Am Coll Cardiol. 2021;78(20):1968-1986doi: 10.1016/j.jacc.2021.08.070.
Palmerini, T., Bruno, A. G., Redfors, B., Valgimigli, M., Taglieri, N., Feres, F., Abizaid, A., Costa, R., Gilard, M., Morice, M. C., Hong, M. K., Kim, B. K., Jang, Y., Kim, H. S., Park, K. W., Colombo, A., Chieffo, A., Nakamura, M., Kotinkaduwa, L. N., Nardi, E., Saia, F., Gasparini, M., Rizzello, G., Weisz, G., Kirtane, A. J., Mehran, R., Witzenbichler, B., Galiè, N., & Stone, G. W. (2021). Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. Journal of the American College of Cardiology, 78(20), 1968-1986. https://doi.org/10.1016/j.jacc.2021.08.070
Palmerini, Tullio, et al. "Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk." Journal of the American College of Cardiology vol. 78,20 (2021): 1968-1986. doi: https://doi.org/10.1016/j.jacc.2021.08.070
Palmerini T, Bruno AG, Redfors B, Valgimigli M, Taglieri N, Feres F, Abizaid A, Costa R, Gilard M, Morice MC, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Nakamura M, Kotinkaduwa LN, Nardi E, Saia F, Gasparini M, Rizzello G, Weisz G, Kirtane AJ, Mehran R, Witzenbichler B, Galiè N, Stone GW. Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. J Am Coll Cardiol. 2021 Nov 16;78(20):1968-1986. doi: 10.1016/j.jacc.2021.08.070. PMID: 34763774.
Copy Download .nbib Format: NLM
Association between poststroke epilepsy and death: A nationwide cohort study.

European stroke journal

Zelano J, Redfors P, Åsberg S, Kumlien E.
PMID: 31008288
Eur Stroke J. 2016 Dec;1(4):272-278. doi: 10.1177/2396987316669000. Epub 2016 Sep 08.

INTRODUCTION: Poststroke epilepsy (PSE) is the most common form of acquired epilepsy after middle age. The primary aim of this study was to study the impact of PSE on prognosis. A secondary aim was to validate recent findings from...

Cite
Zelano J, Redfors P, Åsberg S, et al. Association between poststroke epilepsy and death: A nationwide cohort study. Eur Stroke J. 2016;1(4):272-278doi: 10.1177/2396987316669000.
Zelano, J., Redfors, P., Åsberg, S., & Kumlien, E. (2016). Association between poststroke epilepsy and death: A nationwide cohort study. European stroke journal, 1(4), 272-278. https://doi.org/10.1177/2396987316669000
Zelano, Johan, et al. "Association between poststroke epilepsy and death: A nationwide cohort study." European stroke journal vol. 1,4 (2016): 272-278. doi: https://doi.org/10.1177/2396987316669000
Zelano J, Redfors P, Åsberg S, Kumlien E. Association between poststroke epilepsy and death: A nationwide cohort study. Eur Stroke J. 2016 Dec;1(4):272-278. doi: 10.1177/2396987316669000. Epub 2016 Sep 08. PMID: 31008288; PMCID: PMC6301246.
Copy Download .nbib Format: NLM
Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Triggers, Causes, and Outcome (SECRETO): Rationale and design.

European stroke journal

Putaala J, Martinez-Majander N, Saeed S, Yesilot N, Jäkälä P, Nerg O, Tsivgoulis G, Numminen H, Gordin D, von Sarnowski B, Waje-Andreassen U, Ylikotila P, Roine RO, Zedde M, Huhtakangas J, Fonseca C, Redfors P, de Leeuw FE, Pezzini A, Kõrv J, Schneider S, Tanislav C, Enzinger C, Jatuzis D, Siegerink B, Martínez-Sánchez P, Grau AJ, Palm F, Groop PH, Lanthier S, Ten Cate H, Pussinen P, Paju S, Sinisalo J, Lehto M, Lindgren A, Ferro J, Kittner S, Fazekas F, Gerdts E, Tatlisumak T.
PMID: 31008307
Eur Stroke J. 2017 Jun;2(2):116-125. doi: 10.1177/2396987317703210. Epub 2017 Apr 04.

BACKGROUND: Worldwide, about 1.3 million annual ischaemic strokes (IS) occur in adults aged

Cite
Putaala J, Martinez-Majander N, Saeed S, et al. Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Triggers, Causes, and Outcome (SECRETO): Rationale and design. Eur Stroke J. 2017;2(2):116-125doi: 10.1177/2396987317703210.
Putaala, J., Martinez-Majander, N., Saeed, S., Yesilot, N., Jäkälä, P., Nerg, O., Tsivgoulis, G., Numminen, H., Gordin, D., von Sarnowski, B., Waje-Andreassen, U., Ylikotila, P., Roine, R. O., Zedde, M., Huhtakangas, J., Fonseca, C., Redfors, P., de Leeuw, F. E., Pezzini, A., Kõrv, J., Schneider, S., Tanislav, C., Enzinger, C., Jatuzis, D., Siegerink, B., Martínez-Sánchez, P., Grau, A. J., Palm, F., Groop, P. H., Lanthier, S., Ten Cate, H., Pussinen, P., Paju, S., Sinisalo, J., Lehto, M., Lindgren, A., Ferro, J., Kittner, S., Fazekas, F., Gerdts, E., & Tatlisumak, T. (2017). Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Triggers, Causes, and Outcome (SECRETO): Rationale and design. European stroke journal, 2(2), 116-125. https://doi.org/10.1177/2396987317703210
Putaala, Jukka, et al. "Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Triggers, Causes, and Outcome (SECRETO): Rationale and design." European stroke journal vol. 2,2 (2017): 116-125. doi: https://doi.org/10.1177/2396987317703210
Putaala J, Martinez-Majander N, Saeed S, Yesilot N, Jäkälä P, Nerg O, Tsivgoulis G, Numminen H, Gordin D, von Sarnowski B, Waje-Andreassen U, Ylikotila P, Roine RO, Zedde M, Huhtakangas J, Fonseca C, Redfors P, de Leeuw FE, Pezzini A, Kõrv J, Schneider S, Tanislav C, Enzinger C, Jatuzis D, Siegerink B, Martínez-Sánchez P, Grau AJ, Palm F, Groop PH, Lanthier S, Ten Cate H, Pussinen P, Paju S, Sinisalo J, Lehto M, Lindgren A, Ferro J, Kittner S, Fazekas F, Gerdts E, Tatlisumak T. Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Triggers, Causes, and Outcome (SECRETO): Rationale and design. Eur Stroke J. 2017 Jun;2(2):116-125. doi: 10.1177/2396987317703210. Epub 2017 Apr 04. PMID: 31008307; PMCID: PMC6453214.
Copy Download .nbib Format: NLM
Psychometric properties of the Swedish version of the Glasgow Benefit Inventory in otosclerosis subjects.

Laryngoscope investigative otolaryngology

Redfors YD, Jönsson R, Tideholm B, Finizia C.
PMID: 31890887
Laryngoscope Investig Otolaryngol. 2019 Nov 27;4(6):673-677. doi: 10.1002/lio2.320. eCollection 2019 Dec.

OBJECTIVE: To evaluate the psychometric properties of the Swedish version of the Glasgow Benefit Inventory (GBI).METHODS: A prospective multicenter cohort study was conducted. A total of 123 otosclerosis subjects were included in the study. The subjects were divided in...

Cite
Redfors YD, Jönsson R, Tideholm B, et al. Psychometric properties of the Swedish version of the Glasgow Benefit Inventory in otosclerosis subjects. Laryngoscope Investig Otolaryngol. 2019;4(6):673-677doi: 10.1002/lio2.320.
Redfors, Y. D., Jönsson, R., Tideholm, B., & Finizia, C. (2019). Psychometric properties of the Swedish version of the Glasgow Benefit Inventory in otosclerosis subjects. Laryngoscope investigative otolaryngology, 4(6), 673-677. https://doi.org/10.1002/lio2.320
Redfors, Ylva Dahlin, et al. "Psychometric properties of the Swedish version of the Glasgow Benefit Inventory in otosclerosis subjects." Laryngoscope investigative otolaryngology vol. 4,6 (2019): 673-677. doi: https://doi.org/10.1002/lio2.320
Redfors YD, Jönsson R, Tideholm B, Finizia C. Psychometric properties of the Swedish version of the Glasgow Benefit Inventory in otosclerosis subjects. Laryngoscope Investig Otolaryngol. 2019 Nov 27;4(6):673-677. doi: 10.1002/lio2.320. eCollection 2019 Dec. PMID: 31890887; PMCID: PMC6929569.
Copy Download .nbib Format: NLM
High-Resolution Anorectal Manometry - A Prospective Cohort Study in Healthy Infants.

Journal of pediatric gastroenterology and nutrition

Gatzinsky C, Redfors S, Borg H, Linnér C, Sillén U, Sjöström S.
PMID: 34732647
J Pediatr Gastroenterol Nutr. 2021 Nov 02; doi: 10.1097/MPG.0000000000003350. Epub 2021 Nov 02.

OBJECTIVES: Functional gastrointestinal disorders (FGD) are common during early childhood. In severe defecation disorders, anorectal manometry (AM) is done to exclude aganglionosis. High-resolution anorectal manometry (HRAM) can probably improve diagnostics but normative data in infants are scarce. This study...

Cite
Gatzinsky C, Redfors S, Borg H, et al. High-Resolution Anorectal Manometry - A Prospective Cohort Study in Healthy Infants. J Pediatr Gastroenterol Nutr. 2021;doi: 10.1097/MPG.0000000000003350.
Gatzinsky, C., Redfors, S., Borg, H., Linnér, C., Sillén, U., & Sjöström, S. (2021). High-Resolution Anorectal Manometry - A Prospective Cohort Study in Healthy Infants. Journal of pediatric gastroenterology and nutrition, . https://doi.org/10.1097/MPG.0000000000003350
Gatzinsky, Cathrine, et al. "High-Resolution Anorectal Manometry - A Prospective Cohort Study in Healthy Infants." Journal of pediatric gastroenterology and nutrition vol. (2021). doi: https://doi.org/10.1097/MPG.0000000000003350
Gatzinsky C, Redfors S, Borg H, Linnér C, Sillén U, Sjöström S. High-Resolution Anorectal Manometry - A Prospective Cohort Study in Healthy Infants. J Pediatr Gastroenterol Nutr. 2021 Nov 02; doi: 10.1097/MPG.0000000000003350. Epub 2021 Nov 02. PMID: 34732647.
Copy Download .nbib Format: NLM
Clinico-histopathologic and single nuclei RNA sequencing insights into cardiac injury and microthrombi in critical COVID-19.

JCI insight

Brener MI, Hulke ML, Fukuma N, Golob S, Zilinyi RS, Zhou Z, Tzimas C, Russo I, McGroder C, Pfeiffer RD, Chong A, Zhang G, Burkhoff D, Leon MB, Maurer MS, Moses JW, Uhlemann AC, Hibshoosh H, Uriel N, Szabolcs MJ, Redfors B, Marboe CC, Baldwin MR, Tucker NR, Tsai EJ.
PMID: 34905515
JCI Insight. 2021 Dec 14; doi: 10.1172/jci.insight.154633. Epub 2021 Dec 14.

Acute cardiac injury is prevalent in critical COVID-19 and associated with increased mortality. Its etiology remains debated, as initially presumed causes--- myocarditis and cardiac necrosis--- have proven uncommon. To elucidate the pathophysiology of COVID-19-associated cardiac injury, we conducted a...

Cite
Brener MI, Hulke ML, Fukuma N, et al. Clinico-histopathologic and single nuclei RNA sequencing insights into cardiac injury and microthrombi in critical COVID-19. JCI Insight. 2021;doi: 10.1172/jci.insight.154633.
Brener, M. I., Hulke, M. L., Fukuma, N., Golob, S., Zilinyi, R. S., Zhou, Z., Tzimas, C., Russo, I., McGroder, C., Pfeiffer, R. D., Chong, A., Zhang, G., Burkhoff, D., Leon, M. B., Maurer, M. S., Moses, J. W., Uhlemann, A. C., Hibshoosh, H., Uriel, N., Szabolcs, M. J., Redfors, B., Marboe, C. C., Baldwin, M. R., Tucker, N. R., & Tsai, E. J. (2021). Clinico-histopathologic and single nuclei RNA sequencing insights into cardiac injury and microthrombi in critical COVID-19. JCI insight, . https://doi.org/10.1172/jci.insight.154633
Brener, Michael I, et al. "Clinico-histopathologic and single nuclei RNA sequencing insights into cardiac injury and microthrombi in critical COVID-19." JCI insight vol. (2021). doi: https://doi.org/10.1172/jci.insight.154633
Brener MI, Hulke ML, Fukuma N, Golob S, Zilinyi RS, Zhou Z, Tzimas C, Russo I, McGroder C, Pfeiffer RD, Chong A, Zhang G, Burkhoff D, Leon MB, Maurer MS, Moses JW, Uhlemann AC, Hibshoosh H, Uriel N, Szabolcs MJ, Redfors B, Marboe CC, Baldwin MR, Tucker NR, Tsai EJ. Clinico-histopathologic and single nuclei RNA sequencing insights into cardiac injury and microthrombi in critical COVID-19. JCI Insight. 2021 Dec 14; doi: 10.1172/jci.insight.154633. Epub 2021 Dec 14. PMID: 34905515.
Copy Download .nbib Format: NLM
The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients.

Clinica chimica acta; international journal of clinical chemistry

Hammarsten O, Ljungqvist P, Redfors B, Wernbom M, Widing H, Lindahl B, Salahuddin S, Sammantar R, Jha S, Ravn-Fischer A, Brink M, Gisslen M.
PMID: 34998858
Clin Chim Acta. 2022 Jan 05;527:33-37. doi: 10.1016/j.cca.2021.12.030. Epub 2022 Jan 05.

BACKGROUND: Although cardiac troponin T (cTnT) and troponin I(cTnI) are expressed to similar amount in cardiac tissue, cTnI often reach ten-times higher peak levels compared to cTnT in patients with myocardial necrosis such as in acute myocardial infarction (MI)....

Cite
Hammarsten O, Ljungqvist P, Redfors B, et al. The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients. Clin Chim Acta. 2022;527:33-37doi: 10.1016/j.cca.2021.12.030.
Hammarsten, O., Ljungqvist, P., Redfors, B., Wernbom, M., Widing, H., Lindahl, B., Salahuddin, S., Sammantar, R., Jha, S., Ravn-Fischer, A., Brink, M., & Gisslen, M. (2022). The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients. Clinica chimica acta; international journal of clinical chemistry, 52733-37. https://doi.org/10.1016/j.cca.2021.12.030
Hammarsten, Ola, et al. "The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients." Clinica chimica acta; international journal of clinical chemistry vol. 527 (2022): 33-37. doi: https://doi.org/10.1016/j.cca.2021.12.030
Hammarsten O, Ljungqvist P, Redfors B, Wernbom M, Widing H, Lindahl B, Salahuddin S, Sammantar R, Jha S, Ravn-Fischer A, Brink M, Gisslen M. The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients. Clin Chim Acta. 2022 Jan 05;527:33-37. doi: 10.1016/j.cca.2021.12.030. Epub 2022 Jan 05. PMID: 34998858; PMCID: PMC8744390.
Copy Download .nbib Format: NLM
Validation of the Bleeding Academic Research Consortium Bleeding Definition: Towards a Standardized Bleeding Score.

Journal of the American College of Cardiology

Ben-Yehuda O, Redfors B.
PMID: 27151346
J Am Coll Cardiol. 2016 May 10;67(18):2145-2147. doi: 10.1016/j.jacc.2016.03.505.

No abstract available.

Cite
Ben-Yehuda O, Redfors B. Validation of the Bleeding Academic Research Consortium Bleeding Definition: Towards a Standardized Bleeding Score. J Am Coll Cardiol. 2016;67(18):2145-2147doi: 10.1016/j.jacc.2016.03.505.
Ben-Yehuda, O., & Redfors, B. (2016). Validation of the Bleeding Academic Research Consortium Bleeding Definition: Towards a Standardized Bleeding Score. Journal of the American College of Cardiology, 67(18), 2145-2147. https://doi.org/10.1016/j.jacc.2016.03.505
Ben-Yehuda, Ori, and Redfors, Björn. "Validation of the Bleeding Academic Research Consortium Bleeding Definition: Towards a Standardized Bleeding Score." Journal of the American College of Cardiology vol. 67,18 (2016): 2145-2147. doi: https://doi.org/10.1016/j.jacc.2016.03.505
Ben-Yehuda O, Redfors B. Validation of the Bleeding Academic Research Consortium Bleeding Definition: Towards a Standardized Bleeding Score. J Am Coll Cardiol. 2016 May 10;67(18):2145-2147. doi: 10.1016/j.jacc.2016.03.505. PMID: 27151346.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 55 entries